Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers

PURPOSE: Prodrug technology-based combination drug therapy has been exploited as a promising treatment strategy to achieve synergistic lung cancer therapy, reduce drug dose, and decrease side effects. In the present study, we synthesized a pH and glutathione (GSH) sensitive prodrug, cisplatin (CIS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yonglong, Wang, Yi, Liu, Xiguang, Zhou, Jing, Wang, Xintong, Feng, Hui, Liu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701144/
https://www.ncbi.nlm.nih.gov/pubmed/33268983
http://dx.doi.org/10.2147/DDDT.S260253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701144/
https://www.ncbi.nlm.nih.gov/pubmed/33268983
http://dx.doi.org/10.2147/DDDT.S260253

Ejemplares similares